Multipotent stromal cells (MSC) have been considered promising for the regenerative strategies of articular cartilage. However, the MSC chondrogenic differentiation can ultimately lead to the formation of hypertrophic chondrocytes responsible for the calcification of cartilage. To prevent this MSC-dependent production of a calcified matrix in articular site, MSC hypertrophic differentiation has to be carefully controlled. Given that articular cartilage is avascular, we questioned whether in addition to its stimulatory role in the early differentiation of chondrogenic cells, hypoxia may prevent their late hypertrophic conversion. To address this issue, we used two different chondrogenic cell types: human adipose stem/stromal cells (ASC) and chondrogenic ATDC5 cell line.
Introduction
Chondrogenic medium (Insulin) Our data suggest that a 5%O 2 , in addition of being able to chondrogenically commit ASC, inhibits the hypertrophic differentiation of chondrogenic cells. These results make hypoxia an instrumental tool to prevent the formation of a calcified matrix in ASC-based cartilage tissue engineering. On the contrary, 21%O 2 was found to up regulate the terminal differentiation of chondrogenic cells. These data make normoxia a potent factor useful for bone repair through endochondral strategy.
Conclusions and perspectives
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